412 related articles for article (PubMed ID: 19486654)
1. Psychological distress and prostate specific antigen levels in men with and without prostate cancer.
Turner EL; Lane JA; Metcalfe C; Down L; Donovan JL; Hamdy F; Neal D; Vedhara K
Brain Behav Immun; 2009 Nov; 23(8):1073-8. PubMed ID: 19486654
[TBL] [Abstract][Full Text] [Related]
2. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
[TBL] [Abstract][Full Text] [Related]
3. Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Macefield RC; Lane JA; Metcalfe C; Down L; Neal DE; Hamdy FC; Donovan JL
Eur J Cancer; 2009 Sep; 45(14):2569-73. PubMed ID: 19375907
[TBL] [Abstract][Full Text] [Related]
4. Cancer worry is associated with abnormal prostate-specific antigen levels in men participating in a community screening program.
Cohen L; Fouladi RT; Babaian RJ; Bhadkamkar VA; Parker PA; Taylor CC; Smith MA; Gritz ER; Basen-Engquist K
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):610-7. PubMed ID: 12869399
[TBL] [Abstract][Full Text] [Related]
5. Repeating an abnormal prostate-specific antigen (PSA) level: how relevant is a decrease in PSA?
Connolly D; Black A; Murray LJ; Nambirajan T; Keane PF; Gavin A
Prostate Cancer Prostatic Dis; 2009; 12(1):47-51. PubMed ID: 18762815
[TBL] [Abstract][Full Text] [Related]
6. The measurement of psychological distress in men being investigated for the presence of prostate cancer.
Awsare NS; Green JS; Aldwinckle B; Hanbury DC; Boustead GB; McNicholas TA
Prostate Cancer Prostatic Dis; 2008; 11(4):384-9. PubMed ID: 18427569
[TBL] [Abstract][Full Text] [Related]
7. The influence of statin medications on prostate-specific antigen levels.
Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
[TBL] [Abstract][Full Text] [Related]
8. [Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Hérault].
Jegu J; Tretarre B; Grosclaude P; Rebillard X; Bataille V; Malavaud B; Iborra F; Salama G; Rischmann P; Villers A
Prog Urol; 2009 Jul; 19(7):487-98. PubMed ID: 19559380
[TBL] [Abstract][Full Text] [Related]
9. Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study.
Carlsson S; Aus G; Wessman C; Hugosson J
Eur J Cancer; 2007 Sep; 43(14):2109-16. PubMed ID: 17643983
[TBL] [Abstract][Full Text] [Related]
10. Psychological distress in Japanese men with localized prostate cancer.
Namiki S; Saito S; Tochigi T; Numata I; Ioritani N; Arai Y
Int J Urol; 2007 Oct; 14(10):924-9. PubMed ID: 17880290
[TBL] [Abstract][Full Text] [Related]
11. Baseline prostate-specific antigen level and risk of prostate cancer and prostate-specific mortality: diagnosis is dependent on the intensity of investigation.
Connolly D; Black A; Gavin A; Keane PF; Murray LJ
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):271-8. PubMed ID: 18250343
[TBL] [Abstract][Full Text] [Related]
12. Do anxiety and distress increase during active surveillance for low risk prostate cancer?
van den Bergh RC; Essink-Bot ML; Roobol MJ; Schröder FH; Bangma CH; Steyerberg EW
J Urol; 2010 May; 183(5):1786-91. PubMed ID: 20299064
[TBL] [Abstract][Full Text] [Related]
13. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer.
Roth AJ; Rosenfeld B; Kornblith AB; Gibson C; Scher HI; Curley-Smart T; Holland JC; Breitbart W
Cancer; 2003 Jun; 97(11):2910-8. PubMed ID: 12767107
[TBL] [Abstract][Full Text] [Related]
14. Meanings of prostate-specific antigen testing as narrated by men with localized prostate cancer after primary treatment.
Hedestig O; Sandman PO; Widmark A; Rasmussen BH
Scand J Urol Nephrol; 2008; 42(2):101-9. PubMed ID: 17907052
[TBL] [Abstract][Full Text] [Related]
15. Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer.
Schröder FH; Roobol MJ
Curr Opin Urol; 2009 May; 19(3):227-31. PubMed ID: 19357513
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer.
Lehrer S; Diamond EJ; Mamkine B; Droller MJ; Stone NN; Stock RG
BJU Int; 2005 May; 95(7):961-2. PubMed ID: 15839913
[TBL] [Abstract][Full Text] [Related]
17. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
18. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M
Urol J; 2009; 6(3):182-8. PubMed ID: 19711272
[TBL] [Abstract][Full Text] [Related]
19. The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report.
Cyrus-David MS; Weinberg A; Thompson T; Kadmon D
J Urol; 2005 Jun; 173(6):1923-5. PubMed ID: 15879782
[TBL] [Abstract][Full Text] [Related]
20. Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer.
Ulloa EW; Salup R; Patterson SG; Jacobsen PB
Psychooncology; 2009 Jun; 18(6):598-605. PubMed ID: 18942660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
